Disseminated Histoplasmosis in Persons Living with HIV, France and Overseas Territories,1992–2021

Disseminated histoplasmosis is a major issue among persons with advanced HIV in the Americas; it might also affect persons in sub-Saharan Africa, the Caribbean, and Asia and can be mistaken for other infections. By using 1992-2021 data from the French hospital database on HIV, we analyzed 198,798 pe...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Emerging infectious diseases Ročník 31; číslo 7; s. 1377 - 1385
Hlavní autoři: Nacher, Mathieu, Marshall, Esaïe, Bani-Sadr, Firouze, Peugny, Sandrine, Denis, Blandine, Ouedraogo, Elise, Gallien, Sebastien, Meybeck, Agnes, Françoise, Ugo, Adenis, Antoine, Vignier, Nicolas, Couppié, Pierre, Sellier, Pierre, Grabar, Sophie
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States U.S. National Center for Infectious Diseases 01.07.2025
Centers for Disease Control and Prevention
Témata:
ISSN:1080-6040, 1080-6059, 1080-6059
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Disseminated histoplasmosis is a major issue among persons with advanced HIV in the Americas; it might also affect persons in sub-Saharan Africa, the Caribbean, and Asia and can be mistaken for other infections. By using 1992-2021 data from the French hospital database on HIV, we analyzed 198,798 persons with HIV follow-up in France and its overseas territories, identifying 553 (2.8/1,000 person-years) first episodes of disseminated histoplasmosis. Incidence rates varied by site of follow-up: 9.41 in French Guiana, 0.76 in Guadeloupe, 0.62 in Martinique, and 0.079 in mainland France. Incidence rates in France also varied between regions of origin or travel: 4.73 for Central or South America, 1.36 for the Caribbean, and 0.19 for sub-Saharan Africa or Asia. Differences persisted after adjusting for age, sex, CD4 count, and viral load at baseline. Overall, incidence and early death have declined, likely because of antiretroviral drug rollout in France.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1080-6040
1080-6059
1080-6059
DOI:10.3201/eid3107.241931